Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
21,847
-
Share change
-
+21,847
-
Total reported value
-
$2,061,000
-
Price per share
-
$94.34
-
Number of holders
-
1
-
Value change
-
+$2,061,000
-
Number of buys
-
1
Institutional Holders of Edwards Lifesciences C - COM as of Q2 2023
As of 30 Jun 2023,
Edwards Lifesciences C - COM was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
21,847 shares.
The largest 1 holders included
AlphaMark Advisors, LLC.
This page lists
1
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.